Literature DB >> 32019627

One-carbon metabolites, B vitamins and associations with systemic inflammation and angiogenesis biomarkers among colorectal cancer patients: results from the ColoCare Study.

Cornelia M Ulrich1,2, Mary Playdon1,2,3, Rama Kiblawi1,2,4, Andreana N Holowatyj1,2,5, Biljana Gigic6, Stefanie Brezina7, Anne J M R Geijsen8, Jennifer Ose1,2, Tengda Lin1,2, Sheetal Hardikar1,2, Caroline Himbert1,2, Christy A Warby1,2, Jürgen Böhm1,2, Martijn J L Bours9, Fränzel J B van Duijnhoven8, Tanja Gumpenberger7, Dieuwertje E Kok8, Janna L Koole9, Eline H van Roekel9, Petra Schrotz-King10, Arve Ulvik11, Andrea Gsur7, Nina Habermann12, Matty P Weijenberg9, Per Magne Ueland11,13, Martin Schneider6, Alexis Ulrich6.   

Abstract

B vitamins involved in one-carbon metabolism have been implicated in the development of inflammation- and angiogenesis-related chronic diseases, such as colorectal cancer (CRC). Yet, the role of one-carbon metabolism in inflammation and angiogenesis among CRC patients remains unclear. The objective of this study was to investigate associations of components of one-carbon metabolism with inflammation and angiogenesis biomarkers among newly diagnosed CRC patients (n 238) in the prospective ColoCare Study, Heidelberg. We cross-sectionally analysed associations between twelve B vitamins and one-carbon metabolites and ten inflammation and angiogenesis biomarkers from pre-surgery serum samples using multivariable linear regression models. We further explored associations among novel biomarkers in these pathways with Spearman partial correlation analyses. We hypothesised that pyridoxal-5'-phosphate (PLP) is inversely associated with inflammatory biomarkers. We observed that PLP was inversely associated with C-reactive protein (CRP) (r -0·33, Plinear < 0·0001), serum amyloid A (SAA) (r -0·23, Plinear = 0·003), IL-6 (r -0·39, Plinear < 0·0001), IL-8 (r -0·20, Plinear = 0·02) and TNFα (r -0·12, Plinear = 0·045). Similar findings were observed for 5-methyl-tetrahydrofolate and CRP (r -0·14), SAA (r -0·14) and TNFα (r -0·15) among CRC patients. Folate catabolite acetyl-para-aminobenzoylglutamic acid (pABG) was positively correlated with IL-6 (r 0·27, Plinear < 0·0001), and pABG was positively correlated with IL-8 (r 0·21, Plinear < 0·0001), indicating higher folate utilisation during inflammation. Our data support the hypothesis of inverse associations between PLP and inflammatory biomarkers among CRC patients. A better understanding of the role and inter-relation of PLP and other one-carbon metabolites with inflammatory processes among colorectal carcinogenesis and prognosis could identify targets for future dietary guidance for CRC patients.

Entities:  

Keywords:  Angiogenesis; B vitamins; Colorectal cancer; Folate; Inflammation; One-carbon metabolism; Vitamin B6

Year:  2020        PMID: 32019627      PMCID: PMC7425811          DOI: 10.1017/S0007114520000422

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  77 in total

1.  Folate and cancer--timing is everything.

Authors:  Cornelia M Ulrich; John D Potter
Journal:  JAMA       Date:  2007-06-06       Impact factor: 56.272

Review 2.  Energy balance and gastrointestinal cancer: risk, interventions, outcomes and mechanisms.

Authors:  Cornelia M Ulrich; Caroline Himbert; Andreana N Holowatyj; Stephen D Hursting
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-11       Impact factor: 46.802

3.  Vitamin B6 Prevents IL-1β Protein Production by Inhibiting NLRP3 Inflammasome Activation.

Authors:  Peipei Zhang; Kohsuke Tsuchiya; Takeshi Kinoshita; Hiroko Kushiyama; Sofya Suidasari; Mizuki Hatakeyama; Hisanori Imura; Norihisa Kato; Takashi Suda
Journal:  J Biol Chem       Date:  2016-10-12       Impact factor: 5.157

4.  High-throughput, low-volume, multianalyte quantification of plasma metabolites related to one-carbon metabolism using HPLC-MS/MS.

Authors:  Øivind Midttun; Gry Kvalheim; Per Magne Ueland
Journal:  Anal Bioanal Chem       Date:  2012-12-13       Impact factor: 4.142

Review 5.  Mechanistic perspective on the relationship between pyridoxal 5'-phosphate and inflammation.

Authors:  Ligi Paul; Per Magne Ueland; Jacob Selhub
Journal:  Nutr Rev       Date:  2013-03-08       Impact factor: 7.110

6.  VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression.

Authors:  M L George; M G Tutton; F Janssen; A Arnaout; A M Abulafi; S A Eccles; R I Swift
Journal:  Neoplasia       Date:  2001 Sep-Oct       Impact factor: 5.715

Review 7.  Serine, glycine and one-carbon units: cancer metabolism in full circle.

Authors:  Jason W Locasale
Journal:  Nat Rev Cancer       Date:  2013-07-04       Impact factor: 60.716

8.  Low vitamin B(6) plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants.

Authors:  Simone Saibeni; Marco Cattaneo; Maurizio Vecchi; Maddalena Loredana Zighetti; Anna Lecchi; Rossana Lombardi; Gianmichele Meucci; Luisa Spina; Roberto de Franchis
Journal:  Am J Gastroenterol       Date:  2003-01       Impact factor: 10.864

9.  Vitamin B6 Modifies the Immune Cross-Talk between Mononuclear and Colon Carcinoma Cells.

Authors:  H Bessler; M Djaldetti
Journal:  Folia Biol (Praha)       Date:  2016       Impact factor: 0.906

10.  The correlation between colorectal cancer rates of proliferation and apoptosis and systemic cytokine levels; plus their influence upon survival.

Authors:  C Evans; I Morrison; A G Heriot; J B Bartlett; C Finlayson; A G Dalgleish; D Kumar
Journal:  Br J Cancer       Date:  2006-05-22       Impact factor: 7.640

View more
  5 in total

1.  Association of Serum Pyridoxal-5'-Phosphate, Pyridoxal, and PAr with Colorectal Cancer Risk: A Large-Scale Case-Control Study.

Authors:  Lei Xu; Yu-Jing Fang; Meng-Meng Che; Alinuer Abulimiti; Chu-Yi Huang; Cai-Xia Zhang
Journal:  Nutrients       Date:  2022-06-09       Impact factor: 6.706

2.  Higher vitamin B6 status is associated with improved survival among patients with stage I-III colorectal cancer.

Authors:  Andreana N Holowatyj; Jennifer Ose; Biljana Gigic; Tengda Lin; Arve Ulvik; Anne J M R Geijsen; Stefanie Brezina; Rama Kiblawi; Eline H van Roekel; Andreas Baierl; Jürgen Böhm; Martijn J L Bours; Hermann Brenner; Stéphanie O Breukink; Jenny Chang-Claude; Johannes H W de Wilt; William M Grady; Thomas Grünberger; Tanja Gumpenberger; Esther Herpel; Michael Hoffmeister; Eric T P Keulen; Dieuwertje E Kok; Janna L Koole; Katharina Kosma; Ewout A Kouwenhoven; Gry Kvalheim; Christopher I Li; Peter Schirmacher; Petra Schrotz-King; Marie C Singer; Fränzel J B van Duijnhoven; Henk K van Halteren; Kathy Vickers; F Jeroen Vogelaar; Christy A Warby; Evertine Wesselink; Per M Ueland; Alexis B Ulrich; Martin Schneider; Nina Habermann; Ellen Kampman; Matty P Weijenberg; Andrea Gsur; Cornelia M Ulrich
Journal:  Am J Clin Nutr       Date:  2022-08-04       Impact factor: 8.472

3.  Circulating B-vitamin biomarkers and B-vitamin supplement use in relation to quality of life in patients with colorectal cancer: results from the FOCUS consortium.

Authors:  Janna L Koole; Martijn J L Bours; Anne J M R Geijsen; Biljana Gigic; Arve Ulvik; Dieuwertje E Kok; Stefanie Brezina; Jennifer Ose; Andreas Baierl; Jürgen Böhm; Hermann Brenner; Stéphanie O Breukink; Jenny Chang-Claude; Fränzel J B van Duijnhoven; Peter van Duijvendijk; Tanja Gumpenberger; Nina Habermann; Henk K van Halteren; Michael Hoffmeister; Andreana N Holowatyj; Maryska L G Janssen-Heijnen; Eric T P Keulen; Rama Kiblawi; Flip M Kruyt; Christopher I Li; Tengda Lin; Øivind Midttun; Anita R Peoples; Eline H van Roekel; Martin A Schneider; Petra Schrotz-King; Alexis B Ulrich; Kathy Vickers; Evertine Wesselink; Johannes H W de Wilt; Andrea Gsur; Per M Ueland; Cornelia M Ulrich; Ellen Kampman; Matty P Weijenberg
Journal:  Am J Clin Nutr       Date:  2021-06-01       Impact factor: 7.045

4.  Circulating Folate and Folic Acid Concentrations: Associations With Colorectal Cancer Recurrence and Survival.

Authors:  Anne J M R Geijsen; Arve Ulvik; Biljana Gigic; Dieuwertje E Kok; Fränzel J B van Duijnhoven; Andreana N Holowatyj; Stefanie Brezina; Eline H van Roekel; Andreas Baierl; Michael M Bergmann; Jürgen Böhm; Martijn J L Bours; Hermann Brenner; Stéphanie O Breukink; Mary P Bronner; Jenny Chang-Claude; Johannes H W de Wilt; William M Grady; Thomas Grünberger; Tanja Gumpenberger; Esther Herpel; Michael Hoffmeister; Lyen C Huang; Jolanta D Jedrzkiewicz; Eric T P Keulen; Rama Kiblawi; Torsten Kölsch; Janna L Koole; Katharina Kosma; Ewout A Kouwenhoven; Flip M Kruyt; Gry Kvalheim; Christopher I Li; Tengda Lin; Jennifer Ose; T Bartley Pickron; Courtney L Scaife; Peter Schirmacher; Martin A Schneider; Petra Schrotz-King; Marie C Singer; Eric R Swanson; Peter van Duijvendijk; Henk K van Halteren; Moniek van Zutphen; Kathy Vickers; F Jeroen Vogelaar; Evertine Wesselink; Nina Habermann; Alexis B Ulrich; Per M Ueland; Matty P Weijenberg; Andrea Gsur; Cornelia M Ulrich; Ellen Kampman
Journal:  JNCI Cancer Spectr       Date:  2020-07-07

Review 5.  Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes.

Authors:  Tingting Shi; Hideki Kobara; Kyoko Oura; Tsutomu Masaki
Journal:  J Hepatocell Carcinoma       Date:  2021-02-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.